article thumbnail

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

pharmaphorum

Non-COVID prescription medicines didn’t stop launching during the pandemic — approvals by both the FDA and the EMA were, in fact historically high in both 2020 and 2021. The scope of the problem.

article thumbnail

Dr. Harmony Garges, CMO at ViiV Healthcare, Shares Insights on Positive Findings from the SOLAR Study of Cabenuva

PharmaShots

After obtaining her MD degree and completing her pediatrics residency at Duke University, Harmony pursued her interest in infectious diseases further with fellowships in Pediatric Infectious Diseases and Medical Microbiology at Duke, along with her MPH in Epidemiology from the University of North Carolina at Chapel Hill.